Résultats de recherche
Nombre de programmes trouvés : 84
Conférences
le
(58m17s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Robert ROSENSON)
... disease and to identify and select new drug biotargets.➢ One major question relates to the value of biomarker-guided and/or risk guided therapy and how to design appropriate trials to test these therapeutic strategies. Should therapy be targeted to...
Voir la vidéo
Label UNT Conférences
le
(11m35s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Impact of major clinical trials on ESC Chronic Heart Failure 2012 guidelines. Game changer trials: EMPHASIS-HF, SHIFT, Devices…
... the critical step in establishing higher standards of care for individual patients. Improved guideline uptake is not only an index of better standards but a validation of the process of guideline production.Improving consensus between guidelines is...
Voir la vidéo
Label UNT Conférences
le
(14m5s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Resistant hypertension trials: Can renal denervation therapy lower blood pressure?
... hypertension despite treatment with ?5 antihypertensive drugs, a glomerular filtration rate >45 ml/ min and a suitable renal artery anatomy) making it difficult to extrapolate the results to the general population of patients with resistant hypertension. In...
Voir la vidéo
Conférences
le
(20m53s)
Fernando Brito y la imagen de la violencia / Didier Aubert
... mémoire sur des événements marquants d’un pays. Il a ainsi pour ambition de dresser un état lieux des pratiques et des productions des photojournalistes et des photographes documentaires mexicains au cours des cinquante dernières années. Ce projet...
Voir la vidéo
Label UNT Conférences
le
(37m35s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Expected implications on heart failure epidemiology.
... process of guideline production.Improving consensus between guidelines is also important, differences in recommendations may act as a barrier to guideline. The NICE CHF guidance was updated in 2010, and it is not likely to be revised in short term.Practice...
Voir la vidéo
Label UNT Conférences
le
(32m49s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Is it always safe to believe in class effect: Spironolactone vs. eplerenone differences and clinical relevance?
... care for individual patients. Improved guideline uptake is not only an index of better standards but a validation of the process of guideline production.Improving consensus between guidelines is also important, differences in recommendations may act...
Voir la vidéo
Label UNT Conférences
le
(7m22s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Barostim: Experience so far and future developments
... THERAPYChairpersons: George BAKRIS, Chicago, USA - Sverre E. KJELDSEN, Oslo, NORResistant hypertension is usually defined as uncontrolled hypertension despite the intake of at least 3 antihypertensive drugs in full doses including a diuretic. Most investigators would...
Voir la vidéo
Label UNT Conférences
le
(11m50s)
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Globalization of Diabetes trials: Epidemiology of diabetes in the Middle East and Asian countries
... - Kausik RAY, London, GBRRéalisation, production : Canal U/3S et CERIMESKeyword : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, Baro-stimulation, diabetes...
Voir la vidéo
Label UNT Conférences
le
(14m45s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Resistant hypertension trials: Can renal denervation therapy lower blood pressure?
... antihypertensive drugs in full doses including a diuretic. Most investigators would also claim that this also implies 24-hours systolic blood pressure remaining above 135 (or 140) mmHg. Over the years some evidence has accumulated that raised sympathetic nervous...
Voir la vidéo
Label UNT Conférences
le
(4m14s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate : What relevant endpoints in autonomic nerve modulation therapy trials? What kind/level of evidence? Targets to meet for approval (FDA, and in EU, beyond CE mark) and reimbursement
... defined as uncontrolled hypertension despite the intake of at least 3 antihypertensive drugs in full doses including a diuretic. Most investigators would also claim that this also implies 24-hours systolic blood pressure remaining above 135 (or 140) mmHg....
Voir la vidéo